Related Experiment Video

Updated: Sep 30, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Cdk5 sinks into ALS

Holger Patzke1, Li Huei Tsai

  • 1Dept of Pathology, Harvard Medical School and Howard Hughes Medical Institute, Boston, MA 02115, USA.

Trends in Neurosciences
|January 22, 2002
PubMed

Insights

Deregulated cyclin-dependent kinase 5 (CDK5) activity is implicated in mutant SOD1-mediated diseases. Inhibiting CDK5 may promote motor neuron survival, suggesting a therapeutic target for neurodegenerative conditions like ALS.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pathology

Background:

  • Mutant superoxide dismutase 1 (SOD1) is a key factor in certain neurodegenerative diseases.
  • Cyclin-dependent kinase 5 (CDK5) activity is increasingly recognized for its role in neuronal function and dysfunction.

Purpose of the Study:

  • To investigate the specific involvement of deregulated CDK5 activity in the pathogenesis of mutant SOD1-mediated disease.
  • To explore the potential of CDK5 inhibition as a therapeutic strategy for promoting motor neuron survival.

Main Methods:

  • Analysis of CDK5 activity in cellular and/or animal models of mutant SOD1-mediated disease.
  • Assessment of motor neuron survival following CDK5 inhibition in relevant disease models.

Main Results:

  • Evidence suggests a direct correlation between deregulated CDK5 activity and the progression of mutant SOD1-related pathology.
  • Inhibition of CDK5 activity demonstrated a protective effect, promoting motor neuron survival.

Conclusions:

  • CDK5 plays a significant role in the pathogenesis of mutant SOD1-mediated neurodegeneration.
  • Targeting CDK5 activity presents a promising therapeutic avenue for amyotrophic lateral sclerosis (ALS) and other neurodegenerative disorders.

More Related Videos

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis09:45

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis

Published on: March 31, 2015

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...